Contact
DMCA
Privacy
Robuta
https://pubmed.ncbi.nlm.nih.gov/34272470/
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer...
Gatekeeper mutations are identified in only 50% of the cases at resistance to Anaplastic Lymphoma Kinase (ALK)-tyrosine kinase inhibitors (TKIs). Circulating...
circulating tumor cell
copy number
heterogeneity
alk
non
https://www.mdpi.com/2075-4418/10/3/151
A Novel, Circulating Tumor Cell Enrichment Method Reduces ARv7 False Positivity in Patients with...
Background: The AR-V7 splice variant is a cause of castration-resistant prostate cancer (CRPC).
circulating tumor cell
novel
enrichment
method
reduces